Aequus Pharmaceuticals Inc.
AQSZF
$0.004
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.28% | 27.34% | 18.81% | 4.16% | 6.66% |
| Total Depreciation and Amortization | -5.93% | -5.66% | -5.04% | -1.97% | 0.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 327.66% | -37.27% | -85.78% | -82.87% | -80.46% |
| Change in Net Operating Assets | 356.69% | -25.62% | -105.48% | -132.40% | -54.37% |
| Cash from Operations | 57.29% | 28.44% | -33.52% | -58.57% | -17.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -64.77% | -30.00% | 86.66% | 392.57% | 38.35% |
| Total Debt Repaid | -6.30% | -7.97% | 10.01% | 11.37% | 92.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -69.23% | -33.17% | 99.02% | 565.78% | 3,031.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -532.65% | -240.96% | 63.63% | 89.82% | 102.05% |